semaglutide cardiovascular trial news Long-term kidney outcomes of in obesity and disease in the SELECT Study: Semaglutide slowed progression of

We know that oral semaglutide can be taken in much higher doses as currently approved for obesity, McCoy says

Once the delicate balance between them is disturbed (as in the case of menopause), weight gain often ensues

Appetite Control: Helps you feel fuller for longer, reducing overall calorie intake

Pennsylvania eliminated Medicaid coverage of GLP-1s for weight loss starting in January 2026 and other states may follow

Many patients notice significant improvements in their body composition within 3 to 6 months of starting sermorelin treatment

The first noticeable effect is usually a decrease in appetite and an increased feeling of fullness, which helps patients adhere better to their dietary plans and achieve compounding benefits